Par Drugs And Chemicals Limited (PAR) - Total Assets
Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) holds total assets worth Rs1.29 Billion INR (≈ $13.97 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check PAR total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Par Drugs And Chemicals Limited - Total Assets Trend (2016–2026)
This chart illustrates how Par Drugs And Chemicals Limited's total assets have evolved over time, based on quarterly financial data. Check Par Drugs And Chemicals Limited (PAR) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Par Drugs And Chemicals Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
Par Drugs And Chemicals Limited's total assets of Rs1.29 Billion consist of 49.8% current assets and 50.2% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 32.4% |
| Accounts Receivable | Rs121.39 Million | 9.4% |
| Inventory | Rs53.73 Million | 4.2% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs0.00 | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2016–2026)
This chart illustrates how Par Drugs And Chemicals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Par Drugs And Chemicals Limited.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Par Drugs And Chemicals Limited's current assets represent 49.8% of total assets in 2026, an increase from 25.2% in 2016.
- Cash Position: Cash and equivalents constituted 32.4% of total assets in 2026, up from 1.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 9.4% of total assets.
Par Drugs And Chemicals Limited Competitors by Total Assets
Key competitors of Par Drugs And Chemicals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
SIMCERE PHARMAC. GRP LTD
F:S2P
|
Germany | €14.73 Billion |
|
Curaleaf Holdings Inc.
TO:CURA
|
Canada | CA$2.88 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥11.13 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
Par Drugs And Chemicals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.68 | 3.31 | 2.58 |
| Quick Ratio | 4.29 | 2.94 | 2.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs505.82 Million | Rs382.93 Million | Rs252.06 Million |
Par Drugs And Chemicals Limited - Advanced Valuation Insights
This section examines the relationship between Par Drugs And Chemicals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.96 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 8.2% |
| Total Assets | Rs1.29 Billion |
| Market Capitalization | $12.83 Million USD |
Valuation Analysis
Below Book Valuation: The market values Par Drugs And Chemicals Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Par Drugs And Chemicals Limited's assets grew by 8.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Par Drugs And Chemicals Limited (2016–2026)
The table below shows the annual total assets of Par Drugs And Chemicals Limited from 2016 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs1.29 Billion ≈ $13.97 Million |
+8.23% |
| 2025-03-31 | Rs1.19 Billion ≈ $12.91 Million |
+17.50% |
| 2024-03-31 | Rs1.02 Billion ≈ $10.99 Million |
+14.34% |
| 2023-03-31 | Rs888.68 Million ≈ $9.61 Million |
+12.93% |
| 2022-03-31 | Rs786.90 Million ≈ $8.51 Million |
+3.02% |
| 2021-03-31 | Rs763.84 Million ≈ $8.26 Million |
+27.06% |
| 2020-03-31 | Rs601.15 Million ≈ $6.50 Million |
+17.06% |
| 2019-03-31 | Rs513.55 Million ≈ $5.55 Million |
-4.79% |
| 2018-03-31 | Rs539.39 Million ≈ $5.83 Million |
-3.75% |
| 2017-03-31 | Rs560.41 Million ≈ $6.06 Million |
-3.43% |
| 2016-03-31 | Rs580.31 Million ≈ $6.28 Million |
-- |
About Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more